通过调节VEGF表达和分泌在质母细胞瘤中的表达和分泌,IKBKE调节血管生成
Lin Zhu1, Gaochao Guo2, Yuwei Jin1
1Department of Pathology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, China.
Tissue & cell
|August 13, 2023
概括
抑制IKBKE激酶可以通过降低VEGF降低质母细胞瘤生长和瘤血管生成. 向IKBKE为质母细胞瘤治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- IKBKE (卡帕-β激酶抑制剂epsilon) 是一种炎症激酶,在质母细胞瘤中经常过度表达.
- 它在质母细胞瘤中的致癌作用已确立,但其对瘤血管生成的具体贡献尚不清楚.
研究的目的:
- 调查IKBKE在质母细胞瘤瘤血管生成中的作用.
- 阐明 IKBKE 影响血管生成的潜在分子机制.
主要方法:
- 免疫组织化学 (IHC) 来评估质瘤样本中的IKBKE和VEGF相关性.
- 通过HUVEC测试和西布洛特测试来评估IKBKE通过VEGF调节对血管生成的影响.
- 内质瘤模型研究IKBKE枯竭对瘤生长和血管生成的影响.
主要成果:
- 消耗IKBKE显著抑制了质母细胞瘤瘤的生长和血管生成.
- 发现IKBKE可以诱导VEGF的表达和分泌.
- 该机制涉及IKBKE调节质母细胞瘤细胞中的AKT/FOXO3a通路.
结论:
- IKBKE作为一种新型致癌分子,促进质母细胞瘤血管生成.
- 通过上调调节VEGF表达,IKBKE诱导血管生成.
- 向IKBKE为质母细胞瘤治疗提供了一个有前途的治疗途径.
更多相关视频
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
975
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
8.0K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
